Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,171 headlines found


New tobacco-based influenza vaccine offers promising alternative to traditional egg-based versions: GlobalData

A new tobacco-based seasonal influenza vaccine being developed by Mitsubishi Tanabe Pharma and currently in Phase III studies could potentially rival traditional chicken egg-based vaccines, as it aims to launch in the US for the 2018-19 flu season, accor
Financial Express (in)
added Mar 11, 2016 23:23

CARCIONE: A smoker’s dilemma: quitting the cancer sticks

My first cigarette was at age 21 in Afghanistan after our first firefight...I am lucky, though. The Veteran’s Affairs (VA) hospital supports my decision to quit.... Though this mountain of a task seems insurmountable, I am still dedicated to the effort. E
The Journal (Webster University, St. Louis, MO)
added Feb 19, 2016 16:04

How effective are smoking cessation medications?

Among smokers, no significant differences were found in biochemically confirmed rates of smoking abstinence at 26 weeks regarding use of three methods of medication-based cessation, according to research published in JAMA.
Clinical Advisor
added Feb 9, 2016 18:39

No Efficacy Difference for Chantix, Nicotine Replacement

No significant difference was seen in smoking cessation rates at 6-months and a year among smokers treated with nicotine patches alone, a combination nicotine patches and lozenges, or the anti-smoking drug varenicline (Chantix) in a head-to-head comparis
MedPage Today
added Jan 28, 2016 15:07

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks / A Randomized Clinical Trial

Among adults motivated to quit smoking, 12 weeks of open-label treatment with nicotine patch, varenicline, or C-NRT produced no significant differences in biochemically confirmed rates of smoking abstinence at 26 weeks. The results raise questions about t
JAMA - Journal of the American Medical Association
added Jan 28, 2016 15:08
1 View

No Winners in Patch/Lozenge Combo Study

While varenicline (Chantix) has boasted quit rates higher than the nicotine patch in some prior studies, the drug has not been compared with a combination patch/lozenge strategy, which may offer unique benefits. In this 150-second analysis, MedPage Today
MedPage Today
added Jan 27, 2016 15:56

Smoking cessation pill no better than nicotine patches or lozenges

Smoking cessation pills aren’t any better than nicotine patches or lozenges at helping people successfully quit, a U.S. study suggests. Researchers gave more than 1,000 smokers counseling to help them quit and randomly assigned them to receive three mon
added Jan 27, 2016 00:17

No Clear Winner Seen Among Stop-Smoking Aids in Study

Results of the three approaches did not differ significantly at either six months or a year, the investigators found. At six months, the quit rate was 23 percent for the patch, 24 percent for Chantix, and 27 percent for the combination of patch and lozen
HealthDay [HealthScout]
added Jan 26, 2016 17:48

[Australia] Anti-smoking drug potential link to suicide

An anti-smoking drug has become the focus of forensic scientists in Victoria, as concerns emerge regarding its potential link to suicide. The decision to look into the drug, commercially known as Champix, came directly from Victorian coroner Jacqui Hawk
Neos Kosmos (au)
added Jan 20, 2016 20:54

Smoking Cessation and Nicotine De-addiction Products Market to be Worth US$20.8 bn by 2023: Transparency Market Research

The first line treatment for smoking cessation comprises either nicotine replacement therapy (NRT) products or drug therapy. However, recently people willing to quit smoking are also seen preferring e-cigarettes instead of NRT and drugs. E-cigarettes pro
PR Newswire
added Jan 19, 2016 05:53
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines